Latest Conference Articles

10 Must-See Sessions for Primary Care Physicians at FMX 2025

10 Must-See Sessions for Primary Care Physicians at FMX 2025

October 2nd 2025

FMX

Preview the top sessions at the AAFP Family Medicine Experience (FMX) 2025. From vaccines and obesity care to dementia and LGBTQ+ health, here are 10 highlights for family physicians.

Linus Health Will Highlight Digital Innovations in Early Detection of Cognitive Decline at FMX 2025

Linus Health Will Highlight Digital Innovations in Early Detection of Cognitive Decline at FMX 2025

October 2nd 2025

FMX

Linus Health will demonstrate advances in remote assessment platforms and digital biomarkers of cognitive health that can bring precision medicine to primary care.

FMX 2025: American Academy of Family Physicians Main Stage Speakers

FMX 2025: American Academy of Family Physicians Main Stage Speakers

October 1st 2025

FMX

This year, the FMX Main Stage presenters will be led by Vivek H Murthy, the 21st US Surgeon General. Learn more about him and the 2 other inspiring guests.

Planning to Attend FMX 2025, October 5-9? What Family Physicians Can Expect in Anaheim

Planning to Attend FMX 2025, October 5-9? What Family Physicians Can Expect in Anaheim

September 29th 2025

FMX

The annual meeting of the American Academy of Family Physicians is a unique chance to choose continuing education on just about any topic a family physician could imagine.

RSV Vaccines Found Safe and Effective Across High-Risk Groups in Cochrane Review

RSV Vaccines Found Safe and Effective Across High-Risk Groups in Cochrane Review

September 29th 2025

FMX

Vaccines for respiratory syncytial virus were found both safe and effective across 100,000 participants and, critically, for older adults and infants.

Missing First Mammogram Increases Risk for Future Breast Cancer by More Than 50%, Study Finds

Missing First Mammogram Increases Risk for Future Breast Cancer by More Than 50%, Study Finds

September 25th 2025

FMX

Missing a first screening mammogram was associated with a 53% greater risk of stage III breast cancer and a 40% higher risk of mortality from the disease.

Pooled Cohort Equations vs PREVENT: Statin Exposure Alters ASCVD Risk Predictions

Pooled Cohort Equations vs PREVENT: Statin Exposure Alters ASCVD Risk Predictions

September 23rd 2025

FMX

The study found that although PREVENT-generated risk estimates were more consistent in a broad population, PCE estimates were more accurate in those taking statins.

Pilot Trial Challenges Routine Steroid Use After Pediatric Anaphylaxis ED Discharge

Pilot Trial Challenges Routine Steroid Use After Pediatric Anaphylaxis ED Discharge

September 22nd 2025

FMX

Corticosteroids following resolution of anaphylaxis should be chosen with clear, clinical rationale and reserved for select children, study authors concluded.

FDA Updates Albuterol/Budesonide Label to Include Evidence of Exacerbation Risk Reduction in Mild Asthma

FDA Updates Albuterol/Budesonide Label to Include Evidence of Exacerbation Risk Reduction in Mild Asthma

September 18th 2025

FMX

The updated prescribing information includes phase 3b BATURA trial results showing a 46% reduction in severe exacerbations in mild asthma vs albuterol.

Most Parents Trust Standard Childhood Vaccines, but Many Question Flu and COVID-19 Shots: KFF-Washington Post Survey

Most Parents Trust Standard Childhood Vaccines, but Many Question Flu and COVID-19 Shots: KFF-Washington Post Survey

September 15th 2025

FMX

Most parents support childhood vaccines such as MMR and polio, but skepticism about seasonal and newer shots persists, along with distrust of federal agencies.